Paris-listed global biopharmaceutical company, Ipsen, is acquiring Memo Therapeutics, a Switzerland-based late-stage biotech company for €200m on a cash-free and debt-free basis, and deferred payments contingent upon the achievement of specified development, regulatory approval and sales-based milestones, for a total potential consideration in excess of €700m (US$797m).
Memo Therapeutics is...
Aedifica, Europe’s largest listed healthcare REIT, has signed its first syndicated sustainability-linked credit facility since completion of the exchange offer with Cofinimmo and the S&P credit rating upgrade to BBB+ in March 2026.
The €620m (US$706m) syndicated sustainability-linked Revolving Credit Facility was subscribed by a consortium of eight international banks. The facility has an initial term of five years, with two one-year extension options, and includes an accordion option of up to €100m.
Lenders are ABN AMRO, BNP Paribas Fortis, Intesa Sanpaolo, and Société Générale as bookrunning mandated lead arrangers (MLAs),...